#news #biotech Genentech, Syndax expand HDAC-PD-L1 combination pact

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genentech, Syndax expand HDAC-PD-L1 combination pact .Genentech and Syndax have expanded their exploration of the effects of combining HDAC and PD-L1 inhibitors. The new agreement clears the Roche subsidiary to test its Tecentriq in combination with Syndax’s entinostat in a subset of breast cancer patients.

from FierceBiotech: Biotech http://ift.tt/2EtmWR3